The High Cost of Cheaper Drugs

January 26, 2011

Marcia Boyle, President and Founder, Immune Deficiency Foundation AOL News Thirty years ago my infant son was diagnosed with a rare genetic disorder that make even common cold germs potentially life threatening. His disorder — clinically termed a primary immunodeficiency disease — started me on my career as a patient activist. Read More

Read More


Biologic Drugs: Biosimilars May Be Cheaper, But Are They Safe?

December 14, 2010

Where there’s medicine, there’s money.

Read More


European Union provides a good example of effective biosimilars pathway

December 14, 2010

Biologic drugs can treat a variety of illnesses—including cancer and certain types of arthritis—imore effectively than traditional, chemical based products.

Read More


FDA must establish safe approval pathway for biosimilar drugs

December 14, 2010

Biologic drugs are often referred to as ”miracle drugs“ for good reason…

Read More


Proceed with caution on creating ‘biosimilar’ drugs

November 15, 2010

Americans elected a new Congress on Nov. 2, but the voting booth wasn’t the only place where critical issues were at stake that day.

Read More


The new battle over prescription drugs

November 11, 2010

Away from the spotlight of election news coverage, a committee of the U.S. Food and Drug Administration (FDA) held a hearing in a Washington suburb on the future of biologic drugs…

Read More


Biologics: Are Unsafe Drugs an ‘Acceptable Risk?’ FDA Should Say ‘No!’

November 7, 2010

For cancer patients, what is the “acceptable risk” that a drug will pose safety risks or won’t work properly?

Read More


Understanding the challenges of next generation medicine

November 1, 2010

The English writer Aldous Huxley once said that humanity has “an absolute and infinite capacity for taking things for granted.”

Read More


Clinical Trials Key to Keeping New Drugs Safe

October 29, 2010

Patient safety is a core component of our medical system.

Read More